期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肺血栓栓塞症的溶栓和抗凝治疗 被引量：10

下载PDF
导出
摘要 肺血栓栓塞症（pulmonary thromboembolism,PTE）是肺栓塞（pulmonary embolism,PE）最常见的类型,估计人群年发病率为70/1 000 000[1],急性PTE病情危重常可危及患者的生命,本文复习近期国内外关于PTE诊断和治疗指南,结合笔者的临床实践,重点阐述PTE的溶栓和抗凝治疗方面的若干临床问题,供临床医师参考.
作者 唐家荣
机构地区 华中科技大学同济医学院附属同济医院
出处 《内科急危重症杂志》 2013年第5期263-265,269,共4页 Journal of Critical Care In Internal Medicine
关键词 肺血栓栓塞症 溶栓 抗凝
分类号 R563.5 [医药卫生—呼吸系统]
  • 相关文献

参考文献10

  • 1The EINSTEIN-PE Investigator.Oral rivaroxaban for the treatment of symptomatic pulmonary embolism[J].N Engl J Med,2012,366(14):1287-1297.
  • 2葛均波,徐永健主编.肺血栓栓塞症[M].内科学第8版(全国高等学校教材).北京:人民卫生出版社.2013.99-106.
  • 3Jaff MR,McMurtry MS,Archer SL,et al.Managment of massive and submassive pulmonary embolism,illofemoral deep vein thrombosis and chronic thromboembolic pulmonary hypertension:a scientific statement from the American Heart Association[J].Circulation,2011,123(16):1788-1830.
  • 4Torbicki A,Perrier A,Konstantinides S,et al.Guidelines on the diagnosis and management of acute pulmoranary embolish:the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology(ESC)[J].Eur Heart J,2008,29(18):2276-2315.
  • 5Wang C,Zhai ZG,Yang YH,et al.Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism (A Randomized,Multicenter,Controlled Trial)[J].CHEST,2010,137 (2):254-262.
  • 6Sharifi M,Bay C,Skrocki L,et al.Moderate pulmonary embolish treated with thromobolysis (from the " MOPETT" trial)[J].J Cardiol,2013,111(2):273-277.
  • 7华法林抗凝治疗的中国专家共识[J].中华内科杂志,2013,52(1):76-82. 被引量：597
  • 8Lapner ST,Kearon C.Diagnosis and management of pulmonary embolism(clinical review)[J].BMJ,2013,346:f757.
  • 9The EINSTEIN-PE Investigators,Büller HR,Prins MH,et al.Oral rivaroxaban for the treatment of symptomatic pulmonary embolism[J].N Engl Med,2012,366(14):1287-1292.
  • 10Lee AY,Rickles FR,Julian JA,et al.Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism[J].J Clin Oncol,2005,23(10):2123-2129.

二级参考文献16

  • 1胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量：162
  • 2Hirsh J, Fuster V, Ansell J, et al. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. J Am Coil Cardiol, 2003,41:1633-1652.
  • 3Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007, 146:S57-867.
  • 4Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coil Cardiol, 2008, 52: 865-868.
  • 5Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med, 2005,352:2285-2293.
  • 6Aithal GP, Day CP, Kesteven PJ, et al. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet, 1999, 353:717-719.
  • 7Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141 (2 Suppl) :eddS- 88S.
  • 8Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141 (2 Suppl) :e152S-184S.
  • 9Manolopoulos VG, Ragia G, Tavridou A. Pharmacogenetics of coumarinic oral anticoagulants. Pharmacogenomics, 2010, 11 : 493 -496.
  • 10Schulman S, Parpia S, Stewart C, et al. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial. Ann Intern Med, 2011,155:653-659.

共引文献596

同被引文献72

  • 1段青青,张丽红,张文云,朱瑾,王自强,王保兴,李英.彩色多普勒超声观察深静脉导管纤维蛋白鞘28例分析[J].中国血液净化,2012,11(4):198-201. 被引量：11
  • 2Aujesky D,Perrier A,Roy PM,et al.Validation of a Clinical prognostic model to identify low-risk patients with pulmonary embolism[J].J In- tern Med,2007,261(6):597-604.
  • 3Azemi T,Almahasneh F,Elbash F,et al.Ultrasound-assisted catheter- directed thrombolytic therapy for management of acute pulmonary embol- ism[J].Conn Med,2012,76(4):197-200.
  • 4Sanford DB.Management of a pulmonary artery embolectomy and recur- rent embolus[J].AANA J,2012,80(1):11-15.
  • 5Kucher N.Catheter embolectomy for acute pulmonary embolism[J].Chest,2007,132(2):657-663.
  • 6KucherN,Boekstegers P,Miiller OJ,et al.Randomized,controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute Intermedi- ate-risk pulmonary embolism[J].Circulation,2014,129(4):479-486.
  • 7Quintana D,Salsamendi J,Fourzali R,et al.Ultrasound-assisted cathe- ter-directed thrombolysis in submassive and massive pulmonary embol- ism[J].Cardiovasc Intervent Radiol,2014,37(2):420-426.
  • 8Stein PD,Matta F.Vena cava filters in hospitalised patients with chronic obstructive pulmonary disease and pulmonary embolism[J].Thromb Haemost,2013,109(5):897-900.
  • 9Christoph B, Wiedenroth, Stefan, et al. Chronic thromboembolic pul- monary hypertension after pulmonary embolism, thrombolysis, cathe- ter fragmentation, and embolectomy [ J ]. Thorac Cardiovasc Surg Rep,2014,3 ( 1 ) : 55-57.
  • 10Ali Kemal, Erenler,Turker, et al. Usefulness of heart-type fatty acid binding protein in the emergency department. [ J]. JPMA,2013,63 (9) : 1176-1181.

引证文献10

二级引证文献36

内科急危重症杂志
2013年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部